Mr Patrick Bidulka
My research explores how we can use routinely collected health data to investigate comparative treatment effects where we lack randomised evidence. I focus on comparing
(1) alternative antidiabetic treatments among people with type 2 diabetes and
(2) alternative heart attack treatments among people with kidney disease.
I completed an MSc in epidemiology at London School of Hygiene & Tropical Medicine, and a BSc in pharmacology and economics at McGill University in Montreal, Canada. Alongside my work, I am a PhD candidate.
Prior to joining the LSHTM, I worked at McGill Global Health Programs and the Population Health Research Institute (PHRI) in Hamilton, Canada. I continue to collaborate with researchers at PHRI.
I am a module organiser for the Analysis of Electronic Health Records module.
In addition, I teach on the following MSc modules and short courses:
- Extended Epidemiology
- Statistical Methods in Epidemiology
- Epidemiology in Practice
- Analysis of Electronic Health Records
- Professional Certificate in Pharmacoepidemiology & Pharmacovigilance
I supervise summer projects related to non-communicable disease management and treatment using electronic health records for the following master's courses:
- MSc Epidemiology
- MSc Medical Statistics
- MSc Health Data Science
I also a co-lead and supervise for the Health Data Research (HDR)-UK Black Internship Programme hosted at LSHTM, which aims to reduce the underrepresentation of Black people within the health data science sector.
I am currently involved with several pharmacoepidemiology and health services projects:
- Improving acute cardiac care for patients with kidney disease through linkage of national audits in the UK (IAC-CKD)
- Personalised Medicine for Intensification of Treatment (PERMIT): the case for type 2 diabetes mellitus
- Quality and equity in cardiac care in chronic kidney disease: the promise of big data (QECKD)
- Organised Stroke Care Across Income Levels (OSCAIL)
My research uses routinely collected health care data, mainly from general practices and hospitals in the UK, to:
- Describe services and treatments for type 2 diabetes, cardiovascular disease, and kidney disease in the UK;
- Identify potential inequities in the delivery of these health care services/treatments;
- Compare alternative treatment strategies for type 2 diabetes and cardiovascular disease where clinical equipoise persists.
I work with other epidemiologists, health economists, statisticians, clinicians, and patient representatives to apply advanced methodologies and analyses in this research to reduce the impact of biases in these observational data.